ARTICLE | Company News
Guilford, MAP Medical Technologies Oy deal
January 7, 2002 8:00 AM UTC
GLFD licensed exclusive European development, marketing and distribution rights for its Dopascan imaging agent for Parkinson's disease to MAP Medical. GLFD will receive an upfront payment plus milesto...